Clinical Trial: A Clinical Study to Evaluate Single-agent Therapy of BR113 for Injection in Patients With Advanced Solid Tumors

U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07753590) titled 'A Clinical Study to Evaluate Single-agent Therapy of BR113 for Injection in Patients With Advanced Solid Tumors' on July 29.

Brief Summary: This is a Phase I, multicenter, open-label, single-arm and first-in-human clinical study of BR113 for injection. The study objectives are to evaluate the safety, tolerability, pharmacokinetic profile, anti-tumor activity and immunogenicity of BR113 for injection in patients with advanced malignancies.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: BR113 for injection

Dosage and Administration: BR113 for Injection is administered...